Overview

A Study to Evaluate the Acceptability and Preference for Contraceptive Options as Proxy for HIV Prevention Methods

Status:
Unknown status

Trial end date:
2020-02-28

Target enrollment:

Participant gender:

Summary

This study will enrol sexually active, healthy girls aged 16-17 to assess and compare the acceptability and preference for a monthly vaginal ring, bi-monthly injectable contraception or daily dose oral contraception, as proxy for female-controlled ARV-based HIV prevention methods.

Phase:

N/A

Details

Lead Sponsor:

Desmond Tutu HIV Centre

Treatments:

Contraceptive Agents
Contraceptives, Oral
Ethinyl Estradiol-Norgestrel Combination
Ethinyl estradiol, levonorgestrel drug combination
NuvaRing